Previous 10 | Next 10 |
3 Technical Indicators to Use to Find Penny Stocks to Buy Technical indicators are used to analyze past and current stock price data to predict future performance. They can help investors make informed decisions about when to buy and sell penny stocks . Technical indicators provide inform...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: sfam_photo / Shutterstock.com It’s not every day that Aethlon Medical (NASDAQ: AEMD ) gets this much attention. AEMD stock is soaring today on unusually high volume. What’s the catalyst? Apparently...
Headlines Are Fueling Momentum For These Penny Stocks If you’re looking for the best penny stocks to buy, chances are company headlines are a starting point for you. They aren’t hard to find, most brokers will include them front and center on their trading platforms, and if ...
Aethlon Medical ( NASDAQ: AEMD ) said it signed an agreement with a MedTech Contract Research Organization (CRO) called NAMSA to oversee the company's clinical trials of immunotherapeutic device Hemopurifier for oncology indications. Under the agreement, NAMSA will manage Ae...
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer PR Newswire SAN DIEGO , Jan. 30, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threaten...
Aethlon Medical, Inc. (AEMD) Q2 2022 Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Charles Fisher - Chief Executive Officer James Frakes - Senior Vice President and Chief Financial Officer Steven LaRosa - Chief Medical Officer G...
Aethlon Medical press release ( NASDAQ: AEMD ): Q2 GAAP EPS of -$0.18. As of September 30, 2022, Aethlon Medical had a cash balance of approximately $19.6 million. For further details see: Aethlon Medical GAAP EPS of -$0.18
Aethlon Medical ( NASDAQ: AEMD ) is scheduled to announce Q2 earnings results on Monday, November 14th, after market close. The consensus EPS Estimate is -$0.21 and the consensus Revenue Estimate is $0.07M (-88.7% Y/Y). Over the last 3 months, EPS estimates have seen 1...
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022 PR Newswire SAN DIEGO , Nov. 2, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat ca...
NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual Investor Conference to be held on September 15 th . Individual investors, institutional ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...